A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

Running, not enrolling · Phase 3 · Has a placebo group

Conditions studied: Sickle Cell Disease

In brief

This clinical trial is a Phase 2/3 study that will evaluate the efficacy and safety of etavopivat and test how well etavopivat works compared to placebo to improve the amount of hemoglobin in the blood and to reduce the number of vaso-occlusive crises (times when the blood vessels become blocked and cause pain).

Key facts

Study ID
NCT04624659
Run by
Forma Therapeutics, Inc.
People needed
450
Starts
2021-01-29
Expected to finish
2027-03-19
Last updated by the study team
2026-04-06

Who can join

Age: 12 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.